New injection aims to tackle obesity – early human trial begins

NCT ID NCT06842186

First seen Nov 18, 2025

Summary

This early-stage study tests a new drug, WVE-007, given as a shot under the skin to help with weight loss. It includes about 296 adults who are overweight or have obesity, some with pre-diabetes or type 2 diabetes. The main goal is to check safety and how the drug moves through the body, while also looking at weight-related changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • ARENSIA Research Clinic

    RECRUITING

    Chisinau, MD-2025, Moldova

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Arensia Clinics S.R.L.

    RECRUITING

    Bucharest, 011658, Romania

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Parexel International Early Phase Clinical Unit

    RECRUITING

    Harrow, HA1 3UJ, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Parexel International-EPCU Baltimore

    RECRUITING

    Baltimore, Maryland, 21225, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Simbec-Orion Clinical Pharmacology

    RECRUITING

    Merthyr Tydfil, CF48 4DR, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Spitalul Clinic Judetean De Urgenta Cluj

    RECRUITING

    Cluj-Napoca, 400006, Romania

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.